Linagliptin Impurity 65 | CAS 188111-79-7 - Request Quote
Linagliptin Impurity 65
| SZ CAT No: | SZ-L024101 |
| CAS No | 188111-79-7 |
| Mol.F. | C10H20N2O2 |
| Mol.Wt. | 200.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linagliptin Impurity 65 is chemically Tert-butyl (R)-3-aminopiperidine-1-carboxylate. Linagliptin Impurity 65 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 65 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 188111-79-7
Purchase 188111-79-7
Order 188111-79-7
Enquire 188111-79-7
price of 188111-79-7
188111-79-7 Supplier
188111-79-7 Manufacturer
188111-79-7 Exporter
buy high quality Linagliptin Impurity 65
Purchase Linagliptin Impurity 65
Linagliptin Impurity 65 suppliers
Linagliptin Impurity 65 manufacturers
Linagliptin Impurity 65 price
Order Linagliptin Impurity 65
Enquire Linagliptin Impurity 65
Linagliptin Impurity 65 cost
Linagliptin Impurity 65 Supplier
Linagliptin Impurity 65 Distributor
Linagliptin Impurity 65 for Method Validation
Linagliptin Reference Standard
Linagliptin Impurity 65 for ANDA Filing
Linagliptin Impurity 65 for Forced Degradation Studies
Linagliptin Impurity 65 Identification Standards
Linagliptin Impurity 65 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.